Status:

ACTIVE_NOT_RECRUITING

Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy

Lead Sponsor:

Maastricht University Medical Center

Collaborating Sponsors:

Borstkanker Onderzoek Groep

Dutch Cancer Society

Conditions:

Breast Neoplasms

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

STUDY AIM To decrease the number of breast cancer patients receiving over treatment of the axilla, in order to positively influence the axillary morbidity rate and quality of life. PRIMARY OBJECTIVE ...

Eligibility Criteria

Inclusion

  • Female
  • Aged 18 years or older
  • Pathologically confirmed invasive breast carcinoma
  • A clinical T1-2 tumor
  • Will be treated with lumpectomy and whole breast radiotherapy
  • Clinically node negative status: no signs of axillary lymph node metastases at physical examination and preoperative axillary ultrasound (or negative cyto-/histopathology)
  • Written informed consent

Exclusion

  • Clinically node positive pre-operative
  • Bilateral breast cancer
  • Evidence of metastatic disease
  • History of invasive breast cancer
  • Previous treatment of the axilla with surgery or radiotherapy (except surgery for hidradenitis suppurativa or for other superficially located skin lesions, such as naevi)
  • Pregnant or nursing
  • Other prior malignancies within the past 5 years (except successfully treated basal cell and squamous cell skin cancer, carcinoma in situ of the cervix or carcinoma in situ of the ipsilateral or contralateral breast) or unsuccessfully treated malignancies \> 5 years before randomization
  • Unable or unwilling to give informed consent

Key Trial Info

Start Date :

April 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2027

Estimated Enrollment :

1644 Patients enrolled

Trial Details

Trial ID

NCT02271828

Start Date

April 1 2015

End Date

July 1 2027

Last Update

May 11 2025

Active Locations (22)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (22 locations)

1

Maastricht University Medical Centre+

Maastricht, Limburg, Netherlands, 6202 AZ

2

Jeroen Bosch ziekenhuis

's-Hertogenbosch, Netherlands

3

Flevoziekenhuis

Almere Stad, Netherlands

4

Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital

Amsterdam, Netherlands